Tissue Regenix Group plc Announces Appointment of Steve Couldwell as Chief Executive Officer
November 02, 2017 at 03:00 am EDT
Tissue Regenix Group plc announced the appointment of Steve Couldwell, as Chief Executive Officer of the Group, effective immediately. Steve has been in the position of non- executive director since July 2013. Prior to this Steve held a number of roles at Smith & Nephew including President, Orthopaedics, Europe and Senior VP Sales and Marketing of the Advanced Wound Management business.